Navigation Links
Heart in Biological Technology

REPEL-CV(TM) Adhesion Barrier Receives Endorsement of Kids With Heart

... Barrier has received the endorsement of Kids With heart National Association for Children's heart Disorders, Inc. Michelle L. Rintamaki, Director ... to inform parents of children with congenital heart defects about this new surgical device that ...

Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure

... on the development of novel therapeutics for heart failure patients, today announced dosing of its ... lead product, CD-NP, for the treatment of acute heart failure. The single-blind, ... infused for up to 72 hours in patients with acute heart failure and mild to moderate renal insufficiency. ...

Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate

... A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate. Palatin expects the ... and pharmacodynamic properties. About heart Failure heart failure affects over 5.7 million people in the ...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

... and manufactures miniaturized implantable heart pumps, announced today that the United States ... leader in therapies to address advanced-stage heart failure. The company's product lines include the ... devices implanted in patients suffering from heart failure. Additionally, its International ...

United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients

... biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced ... (Stromal Derived Factor - 1) to treat congestive heart failure. The REGEN trial will enroll 15 patients ... the implantation of MyoCell SDF-1 in congestive heart failure patients post myocardial infarction(s). ...

Symphony Medical Changes Name to CardioPolymers, Inc.

... treat cardiac patients - specifically, congestive heart failure patients with an enlarged left ... centers in Europe, including the German heart Center in Munich where the first three patients ... prevent or reverse the progression of congestive heart failure in patients with dilated cardiomyopathy, ...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

... in adults. Tell the doctor about any heart conditions, including structural abnormalities, ... you or your child develops symptoms that suggest heart problems, such as chest pain or fainting. ... the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; ...

Heart disease: Research off the beating patch

... an amazing sight: What looks like a tiny beating heart is actually a piece of synthetic, gauze-like ... Researchers at The University of Arizona's Sarver heart Center and the Southern Arizona Veterans ... a step closer to repairing hearts damaged by a heart attack or weakened by ...

Nile Therapeutics, Inc. Completes $3.4 Million Private Placement

... on the development of novel therapeutics for heart failure patients, today announced that it has ... our Phase 2 clinical study of CD-NP in acute heart failure patients with mild to moderate renal ... peptide in clinical studies for the treatment of heart failure, and CU-NP, a novel rationally designed ...

Novel gene found for dilated cardiomyopathy

... Researchers in the heart Institute at Cincinnati Children's Hospital ... have discovered a novel gene responsible for heart muscle disease and chronic heart failure in some children and adults with dilated ...

Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System

... information on both the device and a patient's heart health status. The system can also detect ... that comes from knowing both their device and heart health status can be monitored." "Boston ... of Cardiology for the management of Class I heart failure patients. The international ...

Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement

... on the development of novel therapeutics for heart failure patients, today announced that it has ... infused for up to 72 hours in patients with acute heart failure and mild to moderate renal insufficiency. ... of CD-NP's ability to relieve symptoms of acute heart failure and its effects on biomarkers ...

IKARIA(R) to In-License BioLineRx's BL-1040

... catheterization and flows into the damaged heart muscle, where it forms a protective "scaffold" that enhances the mechanical strength of the heart muscle during recovery and repair. BL-1040 is the ... and BL-1040 for the treatment of damaged heart tissue post-acute myocardial infarction. ...

It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer

... that deCODE has linked to increased risk of heart attack and others have linked to type 2 diabetes. ... the leukotriene pathway for the prevention of heart attack; and DG071 and a platform for other PDE4 ... atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProstateCancer(TM) for prostate ...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

... trial in adults. Tell the doctor about any heart conditions, including structural abnormalities, ... you or your child develops symptoms that suggest heart problems, such as chest pain or fainting. ... the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; ...

Cordex Completes Production of ATPace(TM) Clinical Trial Material

... About PSVT PSVT is an episodic, rapid, regular heart rate originating in the atria. The heart rate in PSVT can range from 150 to 250 beats per ... a Phase 2 clinical trial for the treatment of heart failure. In addition, Cordex has a preclinical ...

Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)

... AVENTURA, Fla., June 24 /PRNewswire/ -- Galichia heart Hospital and Mobile Surgery International (MSI) ... Harris, chief executive officer of Galichia heart Hospital. "We have previously proven that ... have implemented this agreement because Galichia heart Hospital offered us the quality of surgical ...

Scientists identify gene vital to early embryonic cells forming a normal heart and skull

... embryonic development on formation of a normal heart and skull. In a study posted online June 15 by ... said Jeffrey Robbins, Ph.D., co-director of the heart Institute at Cincinnati Children's and senior ... to understand congenital malformations of the heart and craniofacial region in people. Especially ...

Berlin Heart Inc. Receives FDA Orphan Product Development Grant

... WOODLANDS, Texas, June 17 /PRNewswire/ -- Berlin heart Inc. today announced it has been awarded an ... Vice President of Clinical Affairs for Berlin heart Inc. will serve as Co-Principal Investigators for ... Berlin Heart EXCOR Pediatric VAD as a Bridge to heart Transplantation." The ...

PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice

... Pumping Function in Dogs with Advanced Chronic heart Failure NEW YORK, June 3 /PRNewswire/ -- ... by Hani N. Sabbah, Ph.D., at the European heart Failure Congress 2009 in Nice, France. The study ... Function in Dogs with Chronic Advanced heart Failure" found that an acute intravenous infusion ...

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

... disorders included cardiac arrest, congestive heart failure, myocardial infarction, cyanosis, ... (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a ...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

... trial in adults. Tell the doctor about any heart conditions, including structural abnormalities, ... you or your child develops symptoms that suggest heart problems, such as chest pain or fainting. ... the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... Myocardial damage may lead to congestive heart failure and may occur as the total cumulative ... be carefully monitored Congestive heart failure or cardiomyopathy may occur after ... myocardial infarction, stroke, congestive heart failure, and hemodialysis vascular access ...

500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device

... The 500th patient was supported with the Berlin heart EXCOR(R) Pediatric Ventricular Assist Device ... cardiomyopathy, a disease that causes the heart muscle to enlarge and weaken. From six months of age, she received medications for her heart disease, but as she progressively worsened, she ...

SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)

... for use in all patients who undergo open heart surgery. REPEL-CV will be marketed throughout ... surgical procedures, often resulting in the heart becoming attached to the sternum and other ... designed to be placed over the surface of the heart at the conclusion of an open-heart surgical ...

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

... transplant rejection in liver, kidney and heart transplant recipients. The approval came on May ... in 2006. Prograf's combination use with MMF for heart transplant recipients was approved by the FDA in ... therapy in the treatment of kidney and heart transplant recipients." "The FDA approval of ...

RSCI Announces World-Leading Stem Cell Science Advisory Board

... and successfully treat patients suffering from heart disease, cancer, diabetes, spinal cord injury, ... pioneer in developing stem cell therapies for heart diseases, Type 2 Diabetes, and serious lung ... He proved the great healing benefit of RSC for heart patients in South American clinical trials in ...

Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452

... activator being developed for the treatment of heart failure. Under the terms of the companies' ... suffering from grievous illnesses, including heart failure. CK-1827452, with its novel mechanism of action, has potential utility in the treatment of heart failure patients around the world. We intend to ...

Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial

... experienced reduced risk of heart attack regardless of heart-attack type ... American College of Cardiology, American heart Association and the World heart Federation Task Force. This post hoc analysis was ...

Low Occurrence of Severe Cardiac Side Effects Despite Extensive Prior Doxorubicin Treatment Reported in Pixantrone Pivotal Trial

... of patients are expected to develop congestive heart failure (CHF). At cumulative doses of ... (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a ...

Atherotech Receives Patent for ApoB Measurement

... in the VAP(R) Cholesterol Test for determining heart disease risk BIRMINGHAM, Ala., May 19 ... to accurately report apoB, the next milestone in heart disease risk assessment. The patent, issued ... elevated apoB values represent increased risk for heart disease. In numerous well-designed prospective ...

Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA

... on the development of novel therapeutics for heart failure patients, received notification from the ... infused for up to 72 hours in patients with acute heart failure and renal insufficiency. The dosing of ... clinical development for the treatment of acute heart failure. CD-NP was designed to reduce symptoms of ...

VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients

... an acute coronary syndrome event such as a heart attack or unstable angina. The randomized, double ... earlier studies reported at the American heart Association 2008 Scientific Sessions in November 2008, and the American heart Association Arteriosclerosis, Thrombosis and ...

deCODE genetics Announces First Quarter 2009 Financial Results

... cardiovascular and metabolic diseases, including heart attack, stroke, atrial fibrillation (AF) ... chromosome 9p21 linked to increased risk of heart attack and types of aneurysm, on chromosome 4q25 ... Cardio(TM) detects genetic risk factors for heart attack, stroke and atrial fibrillation, two types ...

Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions

... at the 30th Annual Scientific Sessions of the heart Rhythm Society, which run from May 13 to 16 in ... Insights into Percent Biventricular Pacing in heart Failure Patients. David L. Hayes, M.D., will ... data for mortality among various sub-groups of heart failure patients receiving CRT therapy. The ...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

... Center, Lincoln, Nebraska. The mechanical heart valve segment will feature the flagship ATS Open Pivot(R) heart Valve and its newest advancement, the ATS Open ... characteristics. The family of ATS mechanical heart valves features a unique open pivot design that ...

University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System

... measure cardiopulmonary gas exchange in heart failure patients. It can make a dramatic ... and ventilation in patients with chronic heart failure and other cardiopulmonary disease. While ... for the device. "It broadens the pool of heart failure patients we are able to accurately test ...

CryoLife Reports Record First Quarter Revenues of $26.7 Million

... the distribution of CryoValve(R) SG pulmonary heart valves increased to $1.2 million in the first ... FDA clearance for the CryoValve(R) SG pulmonary heart valve, processed using CryoLife's proprietary ... risks affecting BioGlue, CryoValve SG pulmonary heart valves and other SynerGraft processed tissues and ...

Vasogen Appoints Dr. Eldon Smith Chairman

... committee responsible for developing a new heart Health Strategy to fight heart disease in Canada. Dr. Smith has served as ... of the Scientific Review Committee of the heart and Stroke Foundation of Canada, and President of ...

deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes

... cardiovascular and metabolic diseases, including heart attack, stroke, atrial fibrillation (AF) and type ... on chromosome 9p21 linked to increased risk of heart attack and aortic aneurysm, SNPs on chromosome ... these markers that predict risk of coronary heart disease and drug response could produce highly ...
Other Contents
(Date:10/15/2014)... Gauß-Allianz has admitted Johannes Gutenberg University Mainz (JGU) ... science hub continues to maintain a significant nationwide ... , "The acceptance of Johannes Gutenberg University Mainz ... a milestone in the national and international competition ... state of Rhineland-Palatinate can be proud that Mainz ...
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology ... today announced the availability of the VeriLook ... Surveillance 3.0 provides real-time biometric face identification using ... digital surveillance cameras. The new version not only ... differentiates people from objects while they are moving ...
(Date:10/14/2014)... One of the planet,s leading questions is how to ... increasingly variable climate. The Food and Agriculture Organization of ... 70% over the next 40 years to feed a ... of the necessary rise in food production. Plants—grains, ... by supporting livestock. Current research must tap into ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/19/2014)... October 19, 2014 DENVER (October 20, ... and Washington State in the outright legalization of recreational ... advice for pro-cannabis activists in those states and elsewhere ... place, or prepare for chaos. , Fox is founder ... is one of Colorado’s first recreational dispensaries. , ...
(Date:10/19/2014)... 19, 2014 Theme and plugin developers from ... Final Cut Pro X entitled ProSketchy. , “ProSketchy allows ... any video project.” Said Christiana Austin, CEO of Pixel Film ... their own sketch style text.” , With ProSketchy users now ... text all with in Final Cut Pro X. Users have ...
(Date:10/18/2014)... The famous review site Top10BestSEOHosting.com has recently compared ... host suppliers carefully, today it announces that HostMonster, GreenGeeks ... the first half of 2014. , HostMonster is ... hosting package helps business companies and individuals get high-powered ... top rated hosting provider, it insists on offering outstanding ...
(Date:10/18/2014)... (PRWEB) October 19, 2014 Bon Secours ... in long-term and rehabilitation care in the Riverdale section ... Beato, chief executive officer, was honored by New Jersey ... CHA Corporate Alumni award at their 30th Annual Gala ... in healthcare administration from New Jersey City University in ...
(Date:10/18/2014)... October 19, 2014 Stafford Communications ... part in the breast cancer awareness program called “Sleep ... movement of pink pajama parties where women and men ... , In support of the program, Stafford’s employees wore ... the Estroven Facebook Page. In exchange, Stafford Communications and ...
Breaking Medicine News(10 mins):Health News:Cannabis CEO Warns Those States Considering a Legal Marijuana Market to Do Their Homework First 2Health News:Cannabis CEO Warns Those States Considering a Legal Marijuana Market to Do Their Homework First 3Health News:Announcing a New Plugin for Final Cut Pro X ProSketchy from Pixel Film Studios 2Health News:Announcing a New Plugin for Final Cut Pro X ProSketchy from Pixel Film Studios 3Health News:Top10BestSEOHosting.com: HostMonster, GreenGeeks And FatCow Are The Best PHP Hosting Suppliers In The First Half Of 2014 2Health News:Carlos G. Beato Honored by New Jersey City University’s Council on Hispanic Affairs (CHA) 2Health News:Carlos G. Beato Honored by New Jersey City University’s Council on Hispanic Affairs (CHA) 3Health News:Stafford Communications Holds Second Annual Celebration to Raise Money for Breast Cancer 2Health News:Stafford Communications Holds Second Annual Celebration to Raise Money for Breast Cancer 3
Other TagsOther Tags